AstraZeneca to seek Japan’s approval of COVID-19 vaccine as early as mid-February: Yomiuri

TOKYO (Reuters) – AstraZeneca Plc will file for Japanese approval of its COVID-19 vaccine as early as mid-February, the Yomiuri newspaper reported, making it the second vaccine maker to seek approval …
( read original story …)